Recently, there has been an increased focus on improving the quality of drug supply data at EU level, underpinned by a number of policy developments, notably the Council of the European Union's conclusions of 15 November 2013 regarding supply and supply reduction within the implementation of the...

Rapid communications bring you the latest findings and discussions in key areas in the drugs field. This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA drug-related infectious diseases indicator, which collects data on the...

Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly administrative data, such as seizures, price, purity and drug-related offences, are used in most countries for assessment of the drug situation and policy evaluation. However,...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts from the PDU network provide prevalence estimates of high-risk drug use by substance and the...